ϳԹ Scaling Reagents for BC Cancer, UBC, and BCCDC COVID-19 Research Program
ϳԹ is helping to formulate reagents at scale for collaborative COVID-19 study
05/22/2020
In a recent interview with BC Cancer Research, Dr. Martin Hirst, Senior Scientist at Canada's Michael Smith Genome Sciences Centre at BC Cancer (GSC), discusses the details of a multi-partner COVID-19 research project involving BC Cancer, the University of British Columbia, and the British Columbia Centre for Disease Control. Dr. Hirst highlights how ϳԹ is helping to formulate and scale reagents to support the project goals for rapid diagnostic testing.
Image source: BC Cancer
Image source: BC Cancer
Latest ϳԹ News
Request Pricing
Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):
Estimated delivery time for your area
Product sample or exclusive offer
In-lab demonstration
By submitting this form, you are providing your consent to ϳԹ Canada Inc. and its subsidiaries and affiliates (“ϳԹ”) to collect and use your information, and send you newsletters and emails in accordance with our privacy policy. Please contact us with any questions that you may have. You can unsubscribe or change your email preferences at any time.
